The regulation of human vascular smooth muscle extracellular matrix protein production by α- and β- adrenoceptor stimulation

Journal of Hypertension

Volumn 20, Issue 2, 2002, Pages 287-294

  O'Callaghan, Christopher J ^a   Williams, Bryan ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Extracellular matrix; Human vascular; Sympathetic nervous system; Transforming growth factor

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ANGIOTENSIN; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BUTOXAMINE; COLLAGEN; FIBRONECTIN; ISOPRENALINE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RNA; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADRENERGIC STIMULATION; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0036464138     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200202000-00019     Document Type: Article

References (33)

1. Sympathetic activation in the pathogenesis of hypertension and progression of target organ damage
2. Adrenergic nervous system in heart failure
3. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome
4. Sympathetic overactivity in patients with chronic renal failure
5. Neurogenic component of chronic renal hypertension
6. Adaptive structural changes of the vascular wall in hypertension and their relationship to control of peripheral resistance
7. Mechanical influences on vascular smooth muscle cell function
8. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rat aorta
9. Sympathoadrenal system is critical for structural changes in genetic hypertension
10. Angiotensin II and the control of cardiovascular structure
11. Reverse remodelling of cardiac myocyte hypertrophy in hypertension and failure by targeting the renin-angiotensin system
12. Pulse wave analysis
13. Is pulse pressure useful in predicting coronary heart disease? The Framingham heart study
14. Transforming growth factor-beta-1 in tissue fibrosis
15. Growth factor expression in aorta of normotensive and hypertensive rats
16. Targeting TGFβ over-expression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
17. Mechanical strain increases extracellular matrix production by human vascular smooth muscle cells: The role of TGFβ
18. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta and tyrosine phosphorylation
19. Sympathetic modulation of radial artery compliance in congestive heart failure
20. Norepinephrine and Ang II stimulate secretion of TGFβ by neonatal rat fibroblasts in vitro
21. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
22. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins
23. Increased serum concentrations of procollagen peptides in essential hypertension
24. Abnormalities of extracellular degradation of collagen type 1 in essential hypertension
25. Serum carboxy-terminal propeptide of procollagen type 1 is a marker of myocardial fibrosis in hypertensive heart disease
26. Transforming growth factor β1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats
27. Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage
28. Transforming growth factor β in hypertensives with cardiorenal damage
29. Biology of glomerular cells in culture
30. Effects of a β-blocker or a converting enzyme inhibitor on small arteries in essential hypertension
31. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonist
32. Reduction of resistance artery stiffness by treatment with the AT-1 receptor antagonist losartan in essential hypertension
33. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan